The pharmaceutical world is seeing a significant shift in blood sugar treatment with the arrival of GLP-1 skin applications. These patches offer a potentially more comfortable alternative to subcutaneous administrations of GLP-1 receptor agonists, lessening the frequency of daily needle sticks. T